Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Pain Burden in Children and Adolescents With Cerebral Palsy

ClinicalTrials.gov ID: NCT04219020

Public ClinicalTrials.gov record NCT04219020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 12:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pain and Pain Burden in Children and Adolescents With Cerebral Palsy - the CPPain Program

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Pain in children and adolescents with cerebral palsy (CP) is a significant health challenge that so far has received too little attention. We lack knowledge on how pain is experienced, its consequences and of perceived support in managing pain. The overarching aim of the CPPain-program is to reduce pain experience, pain interference (e.g. pain burden) in children and adolescents living with CP. CPPain has a prospective cohort comparative design and will include before- and after measurements and process evaluation of a nested intervention. This protocol concerns qualitative and quantitative data collection for the baseline of the CPPain program. The aim of the baseline data collection is to contribute in-depth knowledge of the pain burden in children and adolescents with CP. This knowledge is required to develop targeted pain-diminishing interventions in this vulnerable group of children with a high burden of challenges related to their chronic disease. In the next step, nested intervention will be co-created with children and adolescents with CP, their parents as well as health care professionals, and other professional caregivers involved in or responsible for management of pain based on existing research and baseline findings.

Study identification

NCT ID
NCT04219020
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Sykehuset Telemark
Government
Enrollment
588 participants

Conditions and interventions

Conditions

Interventions

Other

Eligibility (public fields only)

Age range
0 Years to 67 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2020
Primary completion
Aug 30, 2024
Completion
Aug 30, 2024
Last update posted
Oct 15, 2024

2020 – 2024

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Gillette Children's Speciality Healthcare Saint Paul Minnesota 55101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

Recently updated Cerebral Palsy trials

Other public records listing Cerebral Palsy. Sorted by last update posted; newest first. Not a recommendation.

All Cerebral Palsy trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04219020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04219020 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →